You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, May 2021
|
| DOI | 10.1186/s40545-021-00326-7 |
| Pubmed ID | |
| Authors |
Rumiko Shimazawa, Masayuki Ikeda |
X Demographics
The data shown below were collected from the profiles of 2,376 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 469 | 20% |
| United States | 77 | 3% |
| United Kingdom | 28 | 1% |
| Germany | 20 | <1% |
| Netherlands | 15 | <1% |
| Canada | 11 | <1% |
| Austria | 10 | <1% |
| Brazil | 9 | <1% |
| Poland | 8 | <1% |
| Other | 72 | 3% |
| Unknown | 1657 | 70% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2331 | 98% |
| Practitioners (doctors, other healthcare professionals) | 22 | <1% |
| Scientists | 13 | <1% |
| Science communicators (journalists, bloggers, editors) | 7 | <1% |
| Unknown | 3 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 43 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 12% |
| Other | 5 | 12% |
| Student > Master | 5 | 12% |
| Student > Ph. D. Student | 4 | 9% |
| Student > Doctoral Student | 1 | 2% |
| Other | 4 | 9% |
| Unknown | 19 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 19% |
| Nursing and Health Professions | 4 | 9% |
| Biochemistry, Genetics and Molecular Biology | 2 | 5% |
| Social Sciences | 2 | 5% |
| Immunology and Microbiology | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 23 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1387. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2024.
All research outputs
#9,241
of 25,795,662 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#1
of 528 outputs
Outputs of similar age
#434
of 462,055 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 24 outputs
Altmetric has tracked 25,795,662 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 528 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,055 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.